The first mpox vaccine authorised for children will be shipped to DRC in a 3.05 ...
Tris Pharma has received additional ex-US approvals for its ADHD treatments, Qui...
Veeva’s VP of global medical, Christoph Bug, emphasises the importance of scient...
Diagnosed prevalent cases of Parkinson’s disease will grow at 1.94% annually in ...
The EC has granted marketing authorisation for Pfizer's anti-tissue factor pathw...
Discover leading sales enablement and marketing intelligence solutions tailored ...
The UK Minister of State for Science praised the UK’s thriving startup scene at ...
Kura has partnered Kyowa Kirin in a strategic global collaboration for developin...
During AHA 2024, data were presented from the Phase III trial of plozasiran targ...
At AHA 2024, clinical trial results were presented from the ongoing open-label e...
The EMA's CHMP has recommended approval of a combination therapy of BMS's Opdivo...
Tirzepatide is a long-acting dual glucose-dependent insulinotropic polypeptide a...
EMA's CHMP has recommended AstraZeneca's Tagrisso for approval in the European U...
AstraZeneca will advance preclinical and clinical development of the Type 1 Diab...
Intellia presented data from its Phase I study of NTLA-2001 at the 2024 American...
The EC has granted marketing authorisation for Sandoz's Afqlir for the treatment...
